Evolus Inc. (EOLS) |
|
25.7 0.59 (2.35%)
|
03-21 16:00 |
|
Open: |
24.9 |
Pre. Close: |
25.11 |
|
High:
|
25.8 |
Low:
|
24.33 |
|
Volume:
|
733,472 |
Market Cap:
|
701M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
25.822 - 26.004 |
26.004 - 26.146 |
|
Low:
|
24.002 - 24.188 |
24.188 - 24.332 |
|
Close:
|
25.447 - 25.747 |
25.747 - 25.979 |
|
|
|
Technical analysis |
as of: 2019-03-21 4:27:38 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 31.65 One year: 34.46 |
| Support: |
Support1: 23.20 Support2: 19.30 |
| Resistance: |
Resistance1: 27.09 Resistance2: 29.50 |
| Pivot: |
25.49  |
| Moving Average: |
MA(5): 25.21 MA(20): 25.53
MA(100): 18.11 MA(250): 18.53 |
| MACD: |
MACD(12,26): 0.62 Signal(9): 0.92 |
| Stochastic oscillator: |
%K(14,3): 41.16 %D(3): 33.28 |
| RSI: |
RSI(14): 54.20 |
| 52-week: |
High: 39.50 Low: 6.75 Change(%): 125.8 |
| Average Vol(K): |
3-Month: 119695 10-Days: 103042 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.EOLS has closed below upper band by 44.2%. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 20 Mar 2019 21:07:12 Z
NASH, Allergies and Beauty Stocks: Invest or Not?
Tue, 19 Mar 2019 19:08:45 Z
Why Evolus Stock Is Soaring 12% Higher Today
Wed, 06 Mar 2019 16:16:02 Z
Implied Volatility Surging for Evolus (EOLS) Stock Options
Thu, 21 Feb 2019 16:13:44 Z
2 Frustrating Flops, Plus Welcome to the Wrinkle Wars
Wed, 20 Feb 2019 16:15:35 Z
Allergan Responds to Investor's Call for CEO/Chair Role Split
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
27.27 |
| Shares Float (M) |
27.11 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
25.10 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.880 |
|
EPS Est. Current Year
|
|
|
EPS Est. Next Year
|
|
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
-0.560 |
|
Book Value (p.s.)
|
7.140 |
|
PEG Ratio
|
-0.77 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-22.9 |
|
Return on Equity (ttm)
|
-75.5 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14.47 |
|
Levered Free Cash Flow (M)
|
-7.26 |
Stock Valuations |
|
P/E
|
-29.20 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
3.60 |
|
P/S
|
|
|
P/CF
|
-48.44 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
